Metabolic Enzyme Triosephosphate Isomerase 1 and Nicotinamide Phosphoribosyltransferase, Two Independent Inflammatory Indicators in Rheumatoid Arthritis: Evidences From Collagen-Induced Arthritis and Clinical Samples
Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and...
Saved in:
Published in | Frontiers in immunology Vol. 12; p. 795626 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
17.01.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 1664-3224 1664-3224 |
DOI | 10.3389/fimmu.2021.795626 |
Cover
Abstract | Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of
Nampt
and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of
Nampt
+
and
Nampt
++
samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards.
Nampt
overexpression typically occurred in CIA rats during early stages, when
iNos
and
Il-1β
started to be up-regulated. Among differentially expressed genes between
Nampt
+
and
Nampt
++
CIA rat samples, changes of
Tpi1
, the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to
NAMPT
,
TPI1
expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when
NAMPT
and
TPI1
were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted
TPI1
expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation. |
---|---|
AbstractList | Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt+ and Nampt++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt+ and Nampt++ CIA rat samples, changes of Tpi1, the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT, TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation.Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt+ and Nampt++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt+ and Nampt++ CIA rat samples, changes of Tpi1, the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT, TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation. Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt + and Nampt ++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt + and Nampt ++ CIA rat samples, changes of Tpi1 , the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT , TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation. Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of Nampt and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of Nampt+ and Nampt++ samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. Nampt overexpression typically occurred in CIA rats during early stages, when iNos and Il-1β started to be up-regulated. Among differentially expressed genes between Nampt+ and Nampt++ CIA rat samples, changes of Tpi1, the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to NAMPT, TPI1 expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when NAMPT and TPI1 were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted TPI1 expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation. Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis (RA), while other metabolic regulators coordinating NAMPT to perpetuate inflammation are yet to be investigated. We continuously monitored and validated expression changes of and inflammatory indicators in peripheral while blood cells from rats with collagen-induced arthritis (CIA). Gene transcriptional profiles of and samples from identical CIA rats were compared by RNA-sequencing. Observed gene expression changes were validated in another batch of CIA rats, and typical metabolic regulators with persistent changes during inflammatory courses were further investigated in human subjects. According to expression differences of identified genes, RA patients were assigned into different subsets. Clinical manifestation and cytokine profiles among them were compared afterwards. overexpression typically occurred in CIA rats during early stages, when and started to be up-regulated. Among differentially expressed genes between and CIA rat samples, changes of , the only glycolytic enzyme identified were sustained in the aftermath of acute inflammation. Similar to , expression in RA patients was higher than general population, which was synchronized with increase in RFn as well as inflammatory monocytes-related cytokines like Eotaxin. Meanwhile, RANTES levels were relatively low when and were overexpressed. Reciprocal interactions between TPI1 and HIF-1α were observed. HIF-1α promoted expression, while TPI1 co-localized with HIF-1α in nucleus of inflammatory monocytes. In short, although NAMPT and TPI1 dominate different stages of CIA, they similarly provoke monocyte-mediated inflammation. |
Author | Xu, Liang Zuo, Jian Wang, Xiao-Wan Wu, Yi-Jin Li, Yan Lei, Ming Tao, Meng-Qing Yang, Zhe Olatunji, Opeyemi Joshua |
AuthorAffiliation | 2 Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College , Wuhu , China 4 Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China 5 Faculty of Traditional Thai Medicine, Prince of Songkla University , Hat Yai , Thailand 6 Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College , Wuhu , China 1 Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China 3 Department of Rheumatology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China |
AuthorAffiliation_xml | – name: 3 Department of Rheumatology, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China – name: 5 Faculty of Traditional Thai Medicine, Prince of Songkla University , Hat Yai , Thailand – name: 1 Xin’an Medicine Research Center, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China – name: 4 Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) , Wuhu , China – name: 2 Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College , Wuhu , China – name: 6 Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College , Wuhu , China |
Author_xml | – sequence: 1 givenname: Ming surname: Lei fullname: Lei, Ming – sequence: 2 givenname: Meng-Qing surname: Tao fullname: Tao, Meng-Qing – sequence: 3 givenname: Yi-Jin surname: Wu fullname: Wu, Yi-Jin – sequence: 4 givenname: Liang surname: Xu fullname: Xu, Liang – sequence: 5 givenname: Zhe surname: Yang fullname: Yang, Zhe – sequence: 6 givenname: Yan surname: Li fullname: Li, Yan – sequence: 7 givenname: Opeyemi Joshua surname: Olatunji fullname: Olatunji, Opeyemi Joshua – sequence: 8 givenname: Xiao-Wan surname: Wang fullname: Wang, Xiao-Wan – sequence: 9 givenname: Jian surname: Zuo fullname: Zuo, Jian |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35111160$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UstuEzEUHaEiWko_gA3ykgUJnvF4HiyQqiiFSOUhCGvLjzuJK489tT1F4Uv5HDxJi1Ik7sK-8j0P6-o8z06ss5BlL3M8J6Rp33a678d5gYt8Xre0Kqon2VleVeWMFEV5ctSfZhch3OBUZUsIoc-yU0LzVBU-y35_gsiFM1qipf216wGtvXYBhq0Lw5ZHQKvgevA8AMoRtwp91tJFbXmvFaCve5jzWriwM9FzG7o9-A1a_3RoZRUMkA4bU98Z3vc8Or-bBlpObUDaom9bGKeBVujSx63XUYd3aHmXHKyEgK6869HCGcM3YGeJO0o4gu6_tTDaJkmDvvN-MBBeZE87bgJc3N_n2Y-r5XrxcXb95cNqcXk9k2VF46yupWhUUZFWUFFSoWjVCtxwSjnhXIqKyDpXDVVSYCWh40K0jWhqhZumULIj59nqoKscv2GD1z33O-a4ZvsH5zeM-6ilAUabSmKlatw2tBSAW8C1kCInNQeSU5y03h-0hlH0kOxs2qh5JPp4YvWWbdwdaxqc1-0k8PpewLvbEUJkvQ4S0uIsuDGwoipoUeEST9BXx15_TR6ikQD1ASC9C8FDx6SOPGo3WWvDcsymHLJ9DtmUQ3bIYWLm_zAfxP_P-QN7Culz |
CitedBy_id | crossref_primary_10_7717_peerj_14369 crossref_primary_10_1002_mnfr_202200429 crossref_primary_10_1002_ejlt_202200142 crossref_primary_10_3389_fphar_2022_830439 crossref_primary_10_1515_chem_2022_0249 crossref_primary_10_3389_fimmu_2024_1539317 crossref_primary_10_1016_j_phymed_2023_155132 crossref_primary_10_1111_bph_16360 crossref_primary_10_1007_s00011_023_01728_w crossref_primary_10_2147_DDDT_S374827 crossref_primary_10_2147_DDDT_S397914 crossref_primary_10_2147_JIR_S508316 crossref_primary_10_2147_JIR_S378090 crossref_primary_10_1021_acsptsci_4c00470 crossref_primary_10_1093_rheumatology_kead390 crossref_primary_10_1016_j_ghres_2024_100003 crossref_primary_10_1186_s13075_025_03483_1 crossref_primary_10_2147_JIR_S474329 crossref_primary_10_3389_fphar_2024_1403823 crossref_primary_10_2147_JIR_S431600 |
Cites_doi | 10.3389/fimmu.2019.02285 10.1038/nrrheum.2013.39 10.1007/s00216-016-9742-2 10.1038/cddis.2017.132 10.1126/science.1250684 10.1038/s41591-020-0939-8 10.1016/S0002-9440(10)61195-9 10.1038/s41385-020-00356-5 10.1371/journal.pone.0132695 10.2147/JIR.S295957 10.1016/j.jaut.2019.102400 10.1016/j.intimp.2021.107856 10.1155/2015/451319 10.3390/cells9081882 10.1007/s10753-020-01242-9 10.22141/2224-0721.13.1.2017.96762 10.3389/fmed.2018.00024 10.1097/BOR.0000000000000687 10.1007/s10753-018-0932-2 10.1093/rheumatology/keq266 10.3390/cells7100161 10.1007/s40744-019-00189-0 10.1242/dmm.034678 10.1111/imr.12838 10.4155/fmc.12.34 10.1016/j.humimm.2020.02.008 10.1002/art.1780380315 10.1093/rheumatology/kez344 10.1097/MD.0000000000002552 10.1016/j.nbd.2019.104575 10.1136/annrheumdis-2016-210713 10.1016/j.arcmed.2020.01.010 10.1007/s00296-020-04616-2 10.3389/fphar.2020.00197 10.1038/s41556-019-0287-4 10.1016/j.phrs.2018.06.022 10.1038/nrendo.2015.117 10.2147/JIR.S346365 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo. Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo |
Copyright_xml | – notice: Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo. – notice: Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3389/fimmu.2021.795626 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_586c0dd709854be09e07bcb137ae3150 PMC8801790 35111160 10_3389_fimmu_2021_795626 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM CGR CUY CVF ECM EIF IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c465t-77cb8d2639b5b45bd569b08a55a3aacb63c71d85dcb0dcefabb98b87d0882dcf3 |
IEDL.DBID | M48 |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 01:24:23 EDT 2025 Thu Aug 21 18:28:03 EDT 2025 Thu Sep 04 19:53:57 EDT 2025 Thu Jan 02 22:54:52 EST 2025 Tue Jul 01 00:53:36 EDT 2025 Thu Apr 24 22:58:32 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | monocytes nicotinamide phosphoribosyltransferase (NAMPT) glycolysis metabolism reprogramming triosephosphate isomerase 1 (TPI1) rheumatoid arthritis (RA) collagen-induced arthritis (CIA) |
Language | English |
License | Copyright © 2022 Lei, Tao, Wu, Xu, Yang, Li, Olatunji, Wang and Zuo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c465t-77cb8d2639b5b45bd569b08a55a3aacb63c71d85dcb0dcefabb98b87d0882dcf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Daniel Paul Heruth, Children’s Mercy Hospital, United States; Valentina Audrito, University of Turin, Italy Edited by: Andras Perl, Upstate Medical University, United States These authors have contributed equally to this work This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2021.795626 |
PMID | 35111160 |
PQID | 2625260400 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_586c0dd709854be09e07bcb137ae3150 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8801790 proquest_miscellaneous_2625260400 pubmed_primary_35111160 crossref_citationtrail_10_3389_fimmu_2021_795626 crossref_primary_10_3389_fimmu_2021_795626 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-01-17 |
PublicationDateYYYYMMDD | 2022-01-17 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-17 day: 17 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2022 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Cheng (B23) 2014; 345 Yap (B5) 2018; 7 Yang (B18) 2019; 42 Grassi (B2) 2013; 9 Nacarelli (B35) 2019; 21 Stavropoulos-Kalinoglou (B9) 2011; 50 Repossi (B24) 2020; 51 Yang (B26) 2015; 10 Travelli (B15) 2018; 135 Scherer (B1) 2020; 110 Demizio (B6) 2020; 7 Ursini (B10) 2016; 95 Ogger (B30) 2021; 14 Conway (B31) 2018; 11 Singh (B34) 2020; 43 Alvandpur (B4) 2020; 81 Alivernini (B32) 2020; 26 Fu (B28) 2016; 408 Nikiphorou (B21) 2020; 59 Wyman (B13) 2020; 32 Zhang (B33) 2017; 8 Bukach (B7) 2017; 13 Weyand (B36) 2020; 294 von Meyenn (B38) 2019; 10 Garten (B14) 2015; 11 Wang (B19) 2021; 14 Wang (B17) 2021; 98 Wu (B20) 2005; 167 Nam (B3) 2017; 76 Dutta (B22) 2019; 132 Venetsanopoulou (B8) 2020; 40 Nowell (B16) 2012; 4 Soulaidopoulos (B25) 2018; 5 Li (B11) 2015; 2015 Kosgei (B29) 2020; 9 Hirohata (B37) 1995; 38 Zuo (B27) 2021; 14 Hua (B12) 2020; 11 |
References_xml | – volume: 10 year: 2019 ident: B38 article-title: Targeting T Cell Metabolism in Inflammatory Skin Disease publication-title: Front Immunol doi: 10.3389/fimmu.2019.02285 – volume: 9 year: 2013 ident: B2 article-title: Diagnosis of RA-We Have a Dream publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2013.39 – volume: 408 year: 2016 ident: B28 article-title: Metabolomics Profiling of the Free and Total Oxidized Lipids in Urine by LC-MS/MS: Application in Patients With Rheumatoid Arthritis publication-title: Anal Bioanal Chem doi: 10.1007/s00216-016-9742-2 – volume: 8 start-page: e2705 year: 2017 ident: B33 article-title: Metabolic and Molecular Insights Into an Essential Role of Nicotinamide Phosphoribosyltransferase publication-title: Cell Death Dis doi: 10.1038/cddis.2017.132 – volume: 345 start-page: 1250684 year: 2014 ident: B23 article-title: mTOR- and HIF-1α-Mediated Aerobic Glycolysis as Metabolic Basis for Trained Immunity publication-title: Science doi: 10.1126/science.1250684 – volume: 26 start-page: 1 year: 2020 ident: B32 article-title: Distinct Synovial Tissue Macrophage Subsets Regulate Inflammation and Remission in Rheumatoid Arthritis publication-title: Nat Med doi: 10.1038/s41591-020-0939-8 – volume: 167 year: 2005 ident: B20 article-title: Suppression of Matrix Metalloproteinase-9 by Prostaglandin E(2) in Peritoneal Macrophage is Associated With Severity of Endometriosis publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)61195-9 – volume: 14 year: 2021 ident: B30 article-title: Macrophage Metabolic Reprogramming During Chronic Lung Disease publication-title: Mucosal Immunol doi: 10.1038/s41385-020-00356-5 – volume: 10 start-page: e0132695 year: 2015 ident: B26 article-title: Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study publication-title: PloS One doi: 10.1371/journal.pone.0132695 – volume: 14 start-page: 395 year: 2021 ident: B27 article-title: Securidaca Inappendiculata-Derived Xanthones Protected Joints From Degradation in Male Rats With Collagen-Induced Arthritis by Regulating PPAR-γ Signaling publication-title: J Inflammation Res doi: 10.2147/JIR.S295957 – volume: 110 start-page: 102400 year: 2020 ident: B1 article-title: The Etiology of Rheumatoid Arthritis publication-title: J Autoimmun doi: 10.1016/j.jaut.2019.102400 – volume: 98 start-page: 107856 year: 2021 ident: B17 article-title: Nicotinamide Mononucleotide-Elicited NAMPT Signaling Activation Aggravated Adjuvant-Induced Arthritis in Rats by Affecting Peripheral Immune Cells Differentiation publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2021.107856 – volume: 2015 start-page: 451319 year: 2015 ident: B11 article-title: Herb Network Analysis for a Famous TCM Doctor’s Prescriptions on Treatment of Rheumatoid Arthritis publication-title: Evid Based Complement Alternat Med doi: 10.1155/2015/451319 – volume: 9 start-page: 1882 year: 2020 ident: B29 article-title: Sirt1-PPARS Cross-Talk in Complex Metabolic Diseases and Inherited Disorders of the One Carbon Metabolism publication-title: Cells doi: 10.3390/cells9081882 – volume: 43 year: 2020 ident: B34 article-title: Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation publication-title: Inflammation doi: 10.1007/s10753-020-01242-9 – volume: 13 start-page: 79 year: 2017 ident: B7 article-title: Changes of Lipid Metabolism in Patients With Rheumatoid Arthritis and Concomitant Arterial Hypertension, Abdominal Obesity and Diabetes Mellitus Type 2 Depending on the Gene Polymorphism T-786C of Endothelial Nitric Oxide Synthase publication-title: Int J Endocrinol doi: 10.22141/2224-0721.13.1.2017.96762 – volume: 5 year: 2018 ident: B25 article-title: The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis publication-title: Front Med doi: 10.3389/fmed.2018.00024 – volume: 32 year: 2020 ident: B13 article-title: Metabolic Pathways Mediate Pathogenesis and Offer Targets for Treatment in Rheumatic Diseases publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000687 – volume: 42 year: 2019 ident: B18 article-title: Metabolomics Analysis Reveals Therapeutic Effects of α-Mangostin on Collagen-Induced Arthritis in Rats by Down-Regulating Nicotinamide Phosphoribosyltransferase publication-title: Inflammation doi: 10.1007/s10753-018-0932-2 – volume: 50 year: 2011 ident: B9 article-title: Obesity in Rheumatoid Arthritis publication-title: Rheumatol doi: 10.1093/rheumatology/keq266 – volume: 7 start-page: 161 year: 2018 ident: B5 article-title: Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development publication-title: Cells doi: 10.3390/cells7100161 – volume: 7 start-page: 19 year: 2020 ident: B6 article-title: Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis publication-title: Rheumatol Ther doi: 10.1007/s40744-019-00189-0 – volume: 11 start-page: 034678 year: 2018 ident: B31 article-title: Bone Marrow Transplantation Corrects Haemolytic Anaemia in a Novel ENU Mutagenesis Mouse Model of TPI Deficiency publication-title: Dis Model Mech doi: 10.1242/dmm.034678 – volume: 294 year: 2020 ident: B36 article-title: Immunometabolism in the Development of Rheumatoid Arthritis publication-title: Immunol Rev doi: 10.1111/imr.12838 – volume: 4 year: 2012 ident: B16 article-title: PBEF/NAMPT/visfatin: A Promising Drug Target for Treating Rheumatoid Arthritis publication-title: Future Med Chem doi: 10.4155/fmc.12.34 – volume: 81 year: 2020 ident: B4 article-title: Circulating IFN-γ Producing CD4+ T Cells and IL-17A Producing CD4+ T Cells, HLA-Shared Epitope and ACPA may Characterize the Clinical Response to Therapy in Rheumatoid Arthritis Patients publication-title: Hum Immunol doi: 10.1016/j.humimm.2020.02.008 – volume: 38 year: 1995 ident: B37 article-title: Selective Induction of IgM Rheumatoid Factors by CD14+ Monocyte-Lineage Cells Generated From Bone Marrow of Patients With Rheumatoid Arthritis publication-title: Arthritis Rheumatol doi: 10.1002/art.1780380315 – volume: 59 start-page: 997 year: 2020 ident: B21 article-title: Haematological Abnormalities in New-Onset Rheumatoid Arthritis and Risk of Common Infections: A Population-Based Study publication-title: Rheumatology doi: 10.1093/rheumatology/kez344 – volume: 95 start-page: e2552 year: 2016 ident: B10 article-title: Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: An OGTT Study publication-title: Medicine doi: 10.1097/MD.0000000000002552 – volume: 132 start-page: 104575 year: 2019 ident: B22 article-title: RANTES-Induced Invasion of Th17 Cells Into Substantia Nigra Potentiates Dopaminergic Cell Loss in MPTP Mouse Model of Parkinson's Disease publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2019.104575 – volume: 76 year: 2017 ident: B3 article-title: Efficacy of Biological Disease-Modifying Antirheumatic Drugs: A Systematic Literature Review Informing the 2016 Update of the EULAR Recommendations for the Management of Rheumatoid Arthritis publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-210713 – volume: 51 year: 2020 ident: B24 article-title: Molecular Basis of the Beneficial Actions of Resveratrol publication-title: Arch Med Res doi: 10.1016/j.arcmed.2020.01.010 – volume: 40 year: 2020 ident: B8 article-title: The Lipid Paradox in Rheumatoid Arthritis: The Dark Horse of the Augmented Cardiovascular Risk publication-title: Rheumatol Int doi: 10.1007/s00296-020-04616-2 – volume: 11 year: 2020 ident: B12 article-title: Pulsatilla Decoction can Treat the Dampness-Heat Diarrhea Rat Model by Regulating Glycerinphospholipid Metabolism Based Lipidomics Approach publication-title: Front Pharmacol doi: 10.3389/fphar.2020.00197 – volume: 21 start-page: 397 year: 2019 ident: B35 article-title: NAD+ Metabolism Governs the Proinflammatory Senescence-Associated Secretome publication-title: Nat Cell Biol doi: 10.1038/s41556-019-0287-4 – volume: 135 start-page: 25 year: 2018 ident: B15 article-title: NAMPT: A Pleiotropic Modulator of Monocytes and Macrophages publication-title: Pharmacol Res doi: 10.1016/j.phrs.2018.06.022 – volume: 11 year: 2015 ident: B14 article-title: Physiological and Pathophysiological Roles of NAMPT and NAD Metabolism publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2015.117 – volume: 14 year: 2021 ident: B19 article-title: Qing-Luo-Yin Alleviated Experimental Arthritis in Rats by Disrupting Immune Feedback Between Inflammatory T Cells and Monocytes: Key Evidences From Its Effects on Immune Cell Phenotypes publication-title: J Inflammation Res doi: 10.2147/JIR.S346365 |
SSID | ssj0000493335 |
Score | 2.4135478 |
Snippet | Metabolic intervention is a novel anti-rheumatic approach. The glycolytic regulator NAMPT has been identified as a therapeutic target of rheumatoid arthritis... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 795626 |
SubjectTerms | Animals Arthritis, Experimental Arthritis, Rheumatoid - diagnosis Arthritis, Rheumatoid - etiology Arthritis, Rheumatoid - metabolism Biomarkers collagen-induced arthritis (CIA) Computational Biology - methods Cytokines - genetics Cytokines - metabolism Disease Models, Animal Disease Susceptibility Gene Expression Gene Expression Profiling glycolysis Humans Hypoxia-Inducible Factor 1, alpha Subunit - metabolism Immunology Inflammation Mediators - metabolism Macrophage Activation - genetics Macrophage Activation - immunology Macrophages - immunology Macrophages - metabolism metabolism reprogramming monocytes Nicotinamide Phosphoribosyltransferase - genetics Nicotinamide Phosphoribosyltransferase - metabolism Prognosis Rats rheumatoid arthritis (RA) Triose-Phosphate Isomerase - genetics Triose-Phosphate Isomerase - metabolism triosephosphate isomerase 1 (TPI1) |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9NAFB5kQfBFvFtvjOCTGHcmk8kkvqls2RVWRLuwb2FupVmaZElSpP5Sf47nTNKSiuiLb6Vz0h5yvsycb87kO4S88hZWGW9Z5Hi8jBIleJRLPCMG_FYl1nMl8N3h88_p6UXy6VJeTlp94ZmwQR54uHHHMkstc07BxTIxnuWeKWMNF0p7MbJ1lrMJmboa8l4hhBzKmMDC8uNlWVUb4IMxf6uAE6CYwmQhCnr9f0oyfz8rOVl85nfI7TFrpO8Hb--SG76-R24OfSS398nPc99DMNelpSf1j23l6aItw9Z-012vIJukZ12Du0-dp5zq2lEEQF9iM3rn6Zdg1rSlabrtug-pbDB-QxffG3q275Tbw-clQKgKpXkcwB2_pu1oWdOvK7_BgdKhn6sglvSO7rqWdnTeNhXFfQqYweoIW4ZYPzENbo0qpWv6TaNqcfeAXMxPFh9Po7FlQ2STVPaQq1uTuRjSHiNNIo2TaW5YpqXUQmtrUmEVd5l01jC4pUttTJ6ZTDnM9J1diofkqG5q_5jQWCmYjjKtMh8nwsscfk9rp3IsFAHLmxG2i19hRz1zbKuxLoDXYMiLEPICQ14MIZ-R1_tLrgcxj78Zf0BQ7A1Rhzt8AegsRnQW_0LnjLzcQaqA5xaLMbr2zaYrYiCewCVhCp2RRwPE9n-FxV3OUxhRB-A78OVwpC5XQRscpmPUXHvyP5x_Sm7F-LIH4xFXz8hR3278c0jBevMiPG2_AH3MNY0 priority: 102 providerName: Directory of Open Access Journals |
Title | Metabolic Enzyme Triosephosphate Isomerase 1 and Nicotinamide Phosphoribosyltransferase, Two Independent Inflammatory Indicators in Rheumatoid Arthritis: Evidences From Collagen-Induced Arthritis and Clinical Samples |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35111160 https://www.proquest.com/docview/2625260400 https://pubmed.ncbi.nlm.nih.gov/PMC8801790 https://doaj.org/article/586c0dd709854be09e07bcb137ae3150 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ti9NAEF7OE8Ev4vvV02MFP4k5s0k2mwgiKlfvhBPRFvot7FtspEnukhStv9Sf48wmLVcpgl9CyE7SbWZ295mZzTyEPLMaVhmrfc-wIPciETIv5bhHDPxbEWnLRIjfDp9_ik-n0ccZn-2RNb3V8ALbna4d8klNm8Xxz8vVGxjwr9HjhPX2ZV6U5RJcvYAdC4D7QXyNXHfpItzJN6D97z0YDkNHucniOPLAlKM-z7n7KVsrlSvovwuF_r2Z8srqNL5Nbg2wkr7t7eAO2bPVXXKjJ5pc3SO_z20H2l4Ump5Uv1alpZOmcLH_ur2YA9ykZ22N4anWUkZlZShaSFcgW72x9LMTq5tC1e1q0Tms64Rf0MmPmp5tqHQ7OM_BxkqXu8cGDAnWTUuLin6Z2yU2FAb7OXfVlF7RNa1pS8dNXVIMZMAUV3nIKaLtFVHXraGM6YJ-lVjWuL1PpuOTyftTb-B08HQU8w7AvFaJCQAXKa4irgyPU-UnknMZSqlVHGrBTMKNVj680lwqlSYqEQZdAaPz8AHZr-rKHhAaCAHzVSJFYoMotDyF50lpRIqZJHADR8Rf6y_TQ8Fz5N1YZOD4oMozp_IMVZ71Kh-R55tbLvpqH_8SfodGsRHEQt3uQt18y4Zxn_Ek1r4xAmyfR8r6qfWF0oqFQtoQwPiIPF2bVAYDG7M1srL1ss0C8EzB2YQ5dkQe9ia2-SnM_jIWQ4vYMr6tvmy3VMXcFQ-H-RqLsj36n396SG4G-NWHzzwmHpP9rlnaJ4DFOnXkYhhw_DBjR260_QGnDTle |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+Enzyme+Triosephosphate+Isomerase+1+and+Nicotinamide+Phosphoribosyltransferase%2C+Two+Independent+Inflammatory+Indicators+in+Rheumatoid+Arthritis%3A+Evidences+From+Collagen-Induced+Arthritis+and+Clinical+Samples&rft.jtitle=Frontiers+in+immunology&rft.au=Lei%2C+Ming&rft.au=Tao%2C+Meng-Qing&rft.au=Wu%2C+Yi-Jin&rft.au=Xu%2C+Liang&rft.date=2022-01-17&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=12&rft_id=info:doi/10.3389%2Ffimmu.2021.795626&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fimmu_2021_795626 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |